Keritrina

Keritrina Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Keritrina General Information

Description

A generic cardio drug product. The drug Keritrina contains the active pharmaceutical ingredient nitroglycerin which is used for the treatment of heart disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Via Filanda, 5
  • Gessate
  • 20060 Milan
  • Italy
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Keritrina Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Keritrina‘s full profile, request access.

Request a free trial

Keritrina Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Keritrina‘s full profile, request access.

Request a free trial